Latest

Real Estate

Why Realty Income Is the REIT Powerhouse You Didn’t Know You Needed

Why Realty Income Is the REIT Powerhouse You Didn’t Know You Needed

14 March 2025
Realty Income is a REIT celebrated for delivering consistent, monthly dividends over three decades. Recently, it announced its 130th dividend increase, highlighting its financial reliability and investor confidence. Its portfolio includes properties with net leases, providing a stable income stream unaffected by market volatility. In the past year, dividends increased by 4.5%, driven by strong partnerships with companies like 7-Eleven

Bitcoin

Latest

How Power Players Shape the Fate of Bank of America’s Stock

How Power Players Shape the Fate of Bank of America’s Stock

19 April 2025
Institutional investors control 66% of Bank of America, significantly influencing share prices and boardroom decisions. Key institutional stakeholders like Berkshire Hathaway, The Vanguard Group, and BlackRock hold 8.9%, 8.7%, and 6.9% stakes, respectively. The top 25 shareholders combined hold 49% of the
The Power Moves of Two Tech Titans During a March Market Storm

The Power Moves of Two Tech Titans During a March Market Storm

17 April 2025
In March 2025, the Nasdaq-100 index dropped a significant 7.6%, but Strategy Inc. and Electronic Arts managed impressive gains. Strategy Inc. achieved a 12.9% rise by investing heavily in Bitcoin, holding $35.6 billion in reserves, and raising $711 million through preferred stock
A New Contender in Diabetic Neuropathy Care: The Promise of Ketamir-2

A New Contender in Diabetic Neuropathy Care: The Promise of Ketamir-2

16 April 2025
Diabetic neuropathy affects 28% to 55% of diabetes patients, with current treatments offering limited relief and side effects. MIRA Pharmaceuticals’ Ketamir-2, an oral ketamine analog, shows promise in reducing neuropathic pain in diabetic rats. Ketamir-2 avoids psychedelic effects, is non-addictive, and effectively
1 2 3 693

Promo Posts

@Instagram